Profile
ALIM ZTS TAK HLN TEVA ITCI
Company Name Alimera Sciences, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $301.29M $73.16B $47.84B $46.83B $19.50B $14.05B
Employees 0.15K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Mr. Richard S. Eiswirth Jr. Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
Trading
ALIM ZTS TAK HLN TEVA ITCI
Last Close $5.54 $157.23 $14.97 $10.5 $17 $131.87
High 52 $5.6 $196.48 $15.39 $11.41 $22.77 $131.91
Low 52 $5.19 $144.45 $12.89 $8.26 $12.82 $67.99
Price vs. 52 Week High -1.07 % -19.98 % -2.73 % -7.98 % -25.34 % -0.03 %
Price vs. 52 Week Low 6.74 % 8.85 % 16.14 % 27.12 % 32.61 % 93.95 %
Total Return
ALIM ZTS TAK HLN TEVA ITCI
1 Month Return 0 % -3.29 % 2.75 % -5.75 % 0.24 % 0 %
3 Month Return 0 % -3.43 % -0.33 % 4.48 % 8.35 % 0.14 %
6 Month Return 0 % -5.01 % 13.93 % 7.8 % -24.85 % 53.34 %
9 Month Return 0 % -19.32 % 2.18 % -0.85 % -4.17 % 80.13 %
YTD Return 0 % -3.5 % 13.07 % 10.06 % -22.87 % 57.89 %
1 Year Return 0.36 % -8 % 15.87 % 23.53 % 4.62 % 85.5 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALIM ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) 2.87 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) -9.44 % 32.25 % 280.28 % - - -
Growth
ALIM ZTS TAK HLN TEVA ITCI
Asset Growth 260.37 % 0.76 % -9.55 % 87.69 %
Gross Profit Growth 32.54 % -0.19 % 5.47 % 44.88 %
Revenue Growth 49.19 % -0.61 % 4.4 % 46.62 %
Revenue 3 Year -68.19 % 19.01 % 1.52 % 556.51 %
Revenue 5 Year -68.61 % 33.95 % -5.5 % 600974.32 %
Revenue 10 Year 255.29 % 33.95 % -38.45 % 32663.23 %
EBIT Growth 19.15 % 13.52 % -169.63 % 26.77 %
Net Income Growth -11.18 % 37.46 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 24.51 % 4.91 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share 77.56 % 122.63 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share 96.41 % 122.63 % -140.46 % 32.41 %
Operating Income Growth 87.36 % 10.52 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) -42.97 % 9.57 % -8.85 % 41.08 %
Operating 3 Year CFG -30.19 % 71.6 % 52.26 % 77.79 %
Operating 5 Year CFG 77.46 % 196.04 % 123.59 % 69.4 %
Operating 10 Year CFG 96.89 % 196.04 % -81.66 % 10.87 %
EPS Growth 69.5 % 45.45 % -190 % 50.68 %
EPS Diluted Growth 69.5 % 45.45 % -190 % 50.68 %
Book Value Per Share 160.62 % -1.63 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share 215.86 % -37.97 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share 209.67 % -40.16 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share 177.21 % -40.16 % -82.6 % 164.65 %
Dividend Per Share Growth - 49.01 % - -
Dividend 3 Year Growth Per Share - -49.79 % - -
Dividend 5 Year Growth Per Share - -49.97 % -100 % -
Dividend 10 Year Growth Per Share - -49.97 % -100 % -
Debt Growth 52.04 % 6.83 % -10.29 % 0.25 %
Free Cash Flow Growth -777.74 % 16.27 % -11.05 % 40.95 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ALIM ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 73.76 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -8.87 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM -31.87 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM -0.77 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 99.49 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 1337.09 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -1.31 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM 5.86 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 2.06 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 1.96 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 5.8 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 2331 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 50.75 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM 0.08 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM 0.07 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 19.97 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM 5.54 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 94.87 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM 5.86 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM 75.08 32.07 9.73 - 25.68 -191.12
Price To Operating Cash Flows Ratio TTM 71.23 24.98 7.13 - 15.4 -185.85
Price Cash Flow Ratio TTM 71.23 24.98 7.13 - 15.4 -185.85
Income Statement (TTM)
ALIM ZTS TAK HLN TEVA ITCI
Revenue $0.08B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.06B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 75.75% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $-0B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.02B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -0.79 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
ALIM ZTS TAK HLN TEVA ITCI
Long Term Debt $0.06B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.11B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $0.05B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0.07B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.15B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
ALIM ZTS TAK HLN TEVA ITCI
Net Income $-0.02B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $-0B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $-0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0.08B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.255
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.43
ALVO Alvotech 9.42
ALVOW Alvotech 1.7
AMPH Amphastar Pharmaceuticals, Inc. 23.16
AMRX Amneal Pharmaceuticals, Inc. 8.12
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.72
APUS Apimeds Pharmaceuticals US, Inc 1.7183
AQST Aquestive Therapeutics, Inc. 3.255
ASRT Assertio Holdings, Inc. 0.6501
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.28
AYTU Aytu BioPharma, Inc. 2.07
ETFs With Exposure to ALIM
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00462 215.485
VTI Vanguard Total Stock Market Index Fund 0 302.04
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 133.77
IWN iShares Russell 2000 Value ETF 0.00105 157.63
IWO iShares Russell 2000 Growth ETF 0.00841 284.86
VXF Vanguard Extended Market Index Fund 0 191.48
HDG ProShares Hedge Replication ETF 0.000735944 49.33
UWM ProShares Ultra Russell2000 0.00175936 37.59
VTHR Vanguard Russell 3000 Index Fund 0 270.2
IWC iShares Micro-Cap ETF 0.03229 127.655
URTY ProShares UltraPro Russell2000 0.000866593 39.23
VTWV Vanguard Russell 2000 Value Index Fund 0 138.785
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 208.045
VTWO Vanguard Russell 2000 Index Fund 0 87.09
DFUS Dimensional U.S. Equity ETF 0 66.42
DFAC Dimensional U.S. Core Equity 2 ETF 0 35.55
VTSAX Vanguard Total Stock Market Index Fund 0 145.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VITSX Vanguard Total Stock Market Index Fund 0 145.72
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 273.35
RSSL Global X Funds 0.01 84.895
Unlock